<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39337021</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Unveiling the Burden of Hepatitis A in Salerno, Italy: A Comprehensive 9-Year Retrospective Study (2015-2023) on the Seroprevalence of HAV Antibodies and Age/Sex Distribution.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5534</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13185534</ELocationID><Abstract><AbstractText><b>Background:</b> Hepatitis A virus (HAV) infection is a significant global cause of viral hepatitis. At present, the anti-HAV vaccine in Italy is proposed exclusively for specific high-risk groups, and a universal vaccination program is not implemented. <b>Objectives:</b> This study aimed to assess the level of immunity against HAV in patients of both sexes across age groups ranging from 0 to 95 years admitted to the San Giovanni di Dio e Ruggi d'Aragona Hospital in Salerno, Italy, over a 9-year period (2015-2023). <b>Methods:</b> The total HAV seroprevalence by chemiluminescence Vitros system immunodiagnostics (ortho-diagnostics) was obtained by database analysis, stratifying patients for gender and age group in both the pre-pandemic (2015-2019) and pandemic (2020-2023) periods. <b>Results:</b> Out of 28,104 samples collected in 2015-2023, 20,613 resulted positive by total HAV immune screening, with a significant reduction in the annualized proportion of events during the pandemic period compared to the pre-pandemic period. HAV was more abundant in males than females in both periods (exceeding the 70%), with a statistically significant decrease in HAV in females in 2015-2019. The 61-70-year-old age group is more susceptible for both genders, with a strong deviation from the 41-50-year-old age group compared to the 51-60-year-old group. The pandemic period affected the number of analyzed samples in 2020. <b>Conclusions:</b> The study revealed high HAV seroprevalence, especially in males and individuals aged 61-70 years. There was a notable decrease in seroprevalence during the pandemic compared to pre-pandemic years. These results emphasize the need for ongoing monitoring and suggest that a universal vaccination program could address regional immunity gaps and lower disease incidence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Serretiello</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6556-0760</Identifier><AffiliationInfo><Affiliation>Clinical Pathology and Microbiology Unit, San Giovanni di Dio and Ruggi D'Aragona University Hospital, 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iervolino</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0002-1682-3792</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Siervi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0009-0008-2074-1291</Identifier><AffiliationInfo><Affiliation>Clinical Pathology and Microbiology Unit, San Giovanni di Dio and Ruggi D'Aragona University Hospital, 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Pathology and Microbiology Unit, San Giovanni di Dio and Ruggi D'Aragona University Hospital, 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardi</LastName><ForeName>Francesca F</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>U.O.D. Tutela Della Salute e il Coordinamento del Sistema Sanitario Regionale-Regione Campania, 80143 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagliano</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8109-0655</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boccia</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7757-6855</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Salerno, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UOC Hospital and Epidemiological Hygiene, San Giovanni di Dio and Ruggi D'Aragona University Hospital, 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Folliero</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franci</LastName><ForeName>Gianluigi</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3321-4331</Identifier><AffiliationInfo><Affiliation>Clinical Pathology and Microbiology Unit, San Giovanni di Dio and Ruggi D'Aragona University Hospital, 84131 Salerno, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Picornaviridae</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">chemiluminescence</Keyword><Keyword MajorTopicYN="N">hepatitis viruses</Keyword><Keyword MajorTopicYN="N">pandemic period</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">prophylaxis</Keyword><Keyword MajorTopicYN="N">seroprevalence</Keyword><Keyword MajorTopicYN="N">vaccines</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337021</ArticleId><ArticleId IdType="pmc">PMC11432748</ArticleId><ArticleId IdType="doi">10.3390/jcm13185534</ArticleId><ArticleId IdType="pii">jcm13185534</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jacobsen K.H. Globalization and the Changing Epidemiology of Hepatitis A Virus. Cold Spring Harb. Perspect. Med. 2018;8:a031716. doi: 10.1101/cshperspect.a031716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a031716</ArticleId><ArticleId IdType="pmc">PMC6169986</ArticleId><ArticleId IdType="pubmed">29500305</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao G., Jing W., Liu J., Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol. Int. 2021;15:1068–1082. doi: 10.1007/s12072-021-10232-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12072-021-10232-4</ArticleId><ArticleId IdType="pmc">PMC8514357</ArticleId><ArticleId IdType="pubmed">34345993</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunanitthaworn N., Mueangmo O., Saheng J., Wongjak W., Lertsiriladakul T., Chaito T., Nantarat P., Sudjaritruk T. Seroprevalence of hepatitis A virus antibodies among children and adolescents living in Northern Thailand: An implication for hepatitis A immunization. Sci. Rep. 2023;13:17432. doi: 10.1038/s41598-023-44643-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-44643-0</ArticleId><ArticleId IdType="pmc">PMC10575857</ArticleId><ArticleId IdType="pubmed">37833325</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin A., Lemon S.M. Hepatitis A virus: From discovery to vaccines. Hepatology. 2006;43:S164–S172. doi: 10.1002/hep.21052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.21052</ArticleId><ArticleId IdType="pubmed">16447259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemon S.M., Walker C.M. Hepatitis A Virus and Hepatitis E Virus: Emerging and Re-Emerging Enterically Transmitted Hepatitis Viruses. Cold Spring Harb. Perspect. Med. 2018;9:a031823. doi: 10.1101/cshperspect.a031823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a031823</ArticleId><ArticleId IdType="pmc">PMC6531368</ArticleId><ArticleId IdType="pubmed">29735577</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C.M. Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections. Cold Spring Harb. Perspect. Med. 2018;9:a033472. doi: 10.1101/cshperspect.a033472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a033472</ArticleId><ArticleId IdType="pmc">PMC6531370</ArticleId><ArticleId IdType="pubmed">29844218</ArticleId></ArticleIdList></Reference><Reference><Citation>Klevens R.M., Miller J.T., Iqbal K., Thomas A., Rizzo E.M., Hanson H., Sweet K., Phan Q., Cronquist A., Khudyakov Y., et al. The evolving epidemiology of hepatitis a in the United States: Incidence and molecular epidemiology from population-based surveillance, 2005–2007. Arch. Intern. Med. 2010;170:1811–1818. doi: 10.1001/archinternmed.2010.401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2010.401</ArticleId><ArticleId IdType="pubmed">21059974</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz N.G., Revillion M., Roque-Afonso A.M., Dussaix E., Giraud M., Liberpre C., Couturier E., Astagneau E.D. A food-borne outbreak of hepatitis A virus (HAV) infection in a secondary school in Upper Normandy, France, in November 2006. Euro Surveill. 2008;13:18885. doi: 10.2807/ese.13.22.18885-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.13.22.18885-en</ArticleId><ArticleId IdType="pubmed">18761959</ArticleId></ArticleIdList></Reference><Reference><Citation>Croci L., De Medici D., Scalfaro C., Fiore A., Toti L. The survival of hepatitis A virus in fresh produce. Int. J. Food Microbiol. 2001;73:29–34. doi: 10.1016/S0168-1605(01)00689-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1605(01)00689-4</ArticleId><ArticleId IdType="pubmed">11883673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad T., Adnan F., Nadeem M., Kakar S., Anjum S., Saad A., Waheed A., Arshad N. Assessment of the risk for human health of Enterovirus and Hepatitis A virus in clinical and water sources from three metropolitan cities of Pakistan. Ann. Agric. Environ. Med. 2018;25:708–713. doi: 10.26444/aaem/99590.</Citation><ArticleIdList><ArticleId IdType="doi">10.26444/aaem/99590</ArticleId><ArticleId IdType="pubmed">30586962</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin E.-C., Jeong S.-H. Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis A. Cold Spring Harb. Perspect. Med. 2018;8:a031708. doi: 10.1101/cshperspect.a031708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a031708</ArticleId><ArticleId IdType="pmc">PMC6120688</ArticleId><ArticleId IdType="pubmed">29440324</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen K.H., Wiersma S.T. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653–6657. doi: 10.1016/j.vaccine.2010.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.08.037</ArticleId><ArticleId IdType="pubmed">20723630</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheek J.E., Hennessy T.W., Redd J.T., Cobb N., Bryan R.T. Epidemic assistance from the Centers for Disease Control and Prevention involving American Indians and Alaska Natives, 1946–2005. Am. J. Epidemiol. 2011;174:S89–S96. doi: 10.1093/aje/kwr311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwr311</ArticleId><ArticleId IdType="pubmed">22135397</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 8 August 2024)]; Available online:  https://www.cdc.gov/hepatitis/hcp/populations-settings/msm.html#:~:text=Hepatitis%20A%20virus%20(HAV)%2C,the%20virus%20or%20become%20infected.</Citation></Reference><Reference><Citation>Wooten D.A. Forgotten but Not Gone: Learning from the Hepatitis A Outbreak and Public Health Response in San Diego. Top. Antivir. Med. 2019;26:117–121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6372360</ArticleId><ArticleId IdType="pubmed">30641485</ArticleId></ArticleIdList></Reference><Reference><Citation>Havelaar A.H., Kirk M.D., Torgerson P.R., Gibb H.J., Hald T., Lake R.J., Praet N., Bellinger D.C., De Silva N.R., Gargouri N., et al. World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010. PLoS Med. 2015;12:e1001923. doi: 10.1371/journal.pmed.1001923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001923</ArticleId><ArticleId IdType="pmc">PMC4668832</ArticleId><ArticleId IdType="pubmed">26633896</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkan T., Kutlu T., Cullu F., Tümay G.T. A case of vertical transmission of hepatitis A virus infection. Acta Paediatr. 2007;87:1008–1009. doi: 10.1111/j.1651-2227.1998.tb01776.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.1998.tb01776.x</ArticleId><ArticleId IdType="pubmed">9764900</ArticleId></ArticleIdList></Reference><Reference><Citation>Renge R.L., Dani V.S., Chitambar S.D., Arankalle V.A. Vertical transmission of Hepatitis A. Indian J. Pediatr. 2002;69:535–536. doi: 10.1007/BF02722662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02722662</ArticleId><ArticleId IdType="pubmed">12139145</ArticleId></ArticleIdList></Reference><Reference><Citation>Elinav E., Ben–Dov I.Z., Shapira Y., Daudi N., Adler R., Shouval D., Ackerman Z. Acute Hepatitis a Infection in Pregnancy Is Associated with High Rates of Gestational Complications and Preterm Labor. Gastroenterology. 2006;130:1129–1134. doi: 10.1053/j.gastro.2006.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2006.01.007</ArticleId><ArticleId IdType="pubmed">16618407</ArticleId></ArticleIdList></Reference><Reference><Citation>McDuffie R.S., Bader T. Fetal meconium peritonitis after maternal hepatitis A. Am. J. Obstet. Gynecol. 1999;180:1031–1032. doi: 10.1016/S0002-9378(99)70678-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9378(99)70678-2</ArticleId><ArticleId IdType="pubmed">10203675</ArticleId></ArticleIdList></Reference><Reference><Citation>Leikin E., Lysikiewicz A., Garry D., Tejani N. Intrauterine transmission of hepatitis A virus. Obstet. Gynecol. 1996;88:690–691. doi: 10.1016/0029-7844(96)00259-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0029-7844(96)00259-1</ArticleId><ArticleId IdType="pubmed">8841254</ArticleId></ArticleIdList></Reference><Reference><Citation>Daudi N., Shouval D., Stein-Zamir C., Ackerman Z. Breastmilk hepatitis A virus RNA in nursing mothers with acute hepatitis A virus infection. Breastfeed. Med. 2012;7:313–315. doi: 10.1089/bfm.2011.0084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bfm.2011.0084</ArticleId><ArticleId IdType="pubmed">22537111</ArticleId></ArticleIdList></Reference><Reference><Citation>Moro P.L., Museru O.I., Niu M., Lewis P., Broder K. Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women. Am. J. Obstet. Gynecol. 2013;210:561.e1–561.e6. doi: 10.1016/j.ajog.2013.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2013.12.036</ArticleId><ArticleId IdType="pmc">PMC6500450</ArticleId><ArticleId IdType="pubmed">24378675</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt B., Jindal H., Malik J.S., Choudhry S. Vaccination for pregnant women: Need to address. Hum. Vaccines Immunother. 2014;10:3627–3628. doi: 10.4161/hv.32255.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.32255</ArticleId><ArticleId IdType="pmc">PMC4514091</ArticleId><ArticleId IdType="pubmed">25483683</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.H., Kim E.J., Lee J.H., Choi S.S., Kim M.S., Jung S.S., Han G.Y., Yun H.S., Chun D.S., Oh S.S., et al. Molecular characterization of hepatitis A virus isolated from acute gastroenteritis patients in the Seoul region of Korea. Eur. J. Clin. Microbiol. Infect. Dis. 2009;28:1177–1182. doi: 10.1007/s10096-009-0760-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-009-0760-2</ArticleId><ArticleId IdType="pubmed">19466614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes J.A., Fontaine M.J., Gonzalez C.L., Layon A.G., Goodnough L.T., Galel S.A. Case report of a transfusion-associated hepatitis A infection. Transfusion. 2014;54:2202–2206. doi: 10.1111/trf.12648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.12648</ArticleId><ArticleId IdType="pubmed">24689888</ArticleId></ArticleIdList></Reference><Reference><Citation>Galimberti F., Bonomi Boseggia S., Tragni E. Consequences of COVID-19 pandemic on healthcare services. G. Ital. Farm. Farm. 2021;13:5–16.</Citation></Reference><Reference><Citation>Almasio P.L., Amoroso P. HAV infection in chronic liver disease: A rationale for vaccination. Vaccine. 2003;21:2238–2241. doi: 10.1016/S0264-410X(03)00139-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(03)00139-7</ArticleId><ArticleId IdType="pubmed">12744849</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 8 August 2024)].  Available online:  https://www.epicentro.iss.it/epatite/dati-seieva.</Citation></Reference><Reference><Citation> [(accessed on 8 August 2024)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/hepatitis-annual-epidemiological-report-2021.</Citation></Reference><Reference><Citation>Todorova T., Stoykova Z., Kostadinova T. An Increased Occurrence of Viral Hepatitis A during the COVID-19 Pandemic. Infect. Dis. 2021;53:963–964. doi: 10.1080/23744235.2021.1962012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1962012</ArticleId><ArticleId IdType="pubmed">34379035</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone A., Nevola R., Sellitto A., Cozzolino D., Romano C., Cuomo G., Aprea C., Schwartzbaum M.X.P., Ricozzi C., Imbriani S., et al. Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized Study. Clin. Infect. Dis. 2022;75:e403–e409. doi: 10.1093/cid/ciac014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac014</ArticleId><ArticleId IdType="pmc">PMC8807307</ArticleId><ArticleId IdType="pubmed">35084022</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarialioğlu F., Belen F.B., Hayran K.M. Hepatitis A Susceptibility Parallels High COVID-19 Mortality. Turk. J. Med. Sci. 2021;51:382–384. doi: 10.3906/sag-2007-133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-2007-133</ArticleId><ArticleId IdType="pmc">PMC7991879</ArticleId><ArticleId IdType="pubmed">32718125</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Reyes G., Gutierrez-Ruiz M.C., Kershenobich D. Liver fibrosis and chronic viral hepatitis. Arch. Med. Res. 2007;38:644–651. doi: 10.1016/j.arcmed.2006.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2006.10.001</ArticleId><ArticleId IdType="pubmed">17613356</ArticleId></ArticleIdList></Reference><Reference><Citation>Galiero R., Loffredo G., Simeon V., Caturano A., Vetrano E., Medicamento G., Alfano M., Beccia D., Brin C., Colantuoni S., et al. Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy. PLoS ONE. 2024;19:e0296495. doi: 10.1371/journal.pone.0296495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0296495</ArticleId><ArticleId IdType="pmc">PMC11075870</ArticleId><ArticleId IdType="pubmed">38713731</ArticleId></ArticleIdList></Reference><Reference><Citation>Rzymski P., Zarębska-Michaluk D., Genowska A., Tyszko P., Strukcinskiene B., Flisiak R. Trends of Hepatitis A Virus Infection in Poland: Assessing the Potential Impact of the COVID-19 Pandemic and War in Ukraine. Viruses. 2024;16:469. doi: 10.3390/v16030469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16030469</ArticleId><ArticleId IdType="pmc">PMC10975752</ArticleId><ArticleId IdType="pubmed">38543833</ArticleId></ArticleIdList></Reference><Reference><Citation>Petakh P., Tymchyk V., Kamyshnyi O. Communicable diseases in Ukraine during the period of 2018–2023: Impact of the COVID-19 pandemic and war. Travel Med. Infect. Dis. 2024;60:102733. doi: 10.1016/j.tmaid.2024.102733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2024.102733</ArticleId><ArticleId IdType="pubmed">38942160</ArticleId></ArticleIdList></Reference><Reference><Citation>Levican J., Ampuero M., Rabello C., Venegas I., Quarleri J., Gaggero A. Changing molecular epidemiology of Hepatitis A virus in Santiago, Chile from 2010 to 2021. Infect. Genet. Evol. 2023;111:105428. doi: 10.1016/j.meegid.2023.105428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2023.105428</ArticleId><ArticleId IdType="pubmed">36990306</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)   WHO Immunological Basis for Immunization Series: Module 18: Hepatitis A. WHO; Geneva, Switzerland: 2019.  [(accessed on 8 August 2024)].  Update 2019. Available online:  https://apps.who.int/iris/handle/10665/326501.</Citation></Reference><Reference><Citation>Zanella B., Boccalini S., Biamonte M.A., Giorgetti D., Menicacci M., Bonito B., Ninci A., Tiscione E., Puggelli F., Mereu G., et al. A Study of Hepatitis A Seroprevalence in a Paediatric and Adolescent Population of the Province of Florence (Italy) in the Period 2017–2018 Confirms Tuscany a Low Endemic Area. Vaccines. 2021;9:1194. doi: 10.3390/vaccines9101194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101194</ArticleId><ArticleId IdType="pmc">PMC8538179</ArticleId><ArticleId IdType="pubmed">34696301</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagnelli E., Stroffolini T., Almasio P., Mele A., Coppola N., Ferrigno L., Scolastico C., Onofrio M., Imparato M., Filippini P. Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study. J. Viral Hepat. 2005;13:67–71. doi: 10.1111/j.1365-2893.2005.00659.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2893.2005.00659.x</ArticleId><ArticleId IdType="pubmed">16364085</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansaldi F., Bruzzone B., Rota M.C., Bella A., Ciofi degli Atti M., Durando P., Gasparini R., Icardi G., Serologic Study Group Hepatitis A incidence and hospital-based seroprevalence in Italy: A nation-wide study. Eur. J. Epidemiol. 2007;23:45–53. doi: 10.1007/s10654-007-9198-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-007-9198-y</ArticleId><ArticleId IdType="pubmed">17978852</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong G.L., Bell B.P. Hepatitis A virus infections in the United States: Model-based estimates and implications for childhood immunization. Pediatrics. 2002;109:839–845. doi: 10.1542/peds.109.5.839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.5.839</ArticleId><ArticleId IdType="pubmed">11986444</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)   WHO Position Paper on Hepatitis A Vaccines. WHO; Geneva, Switzerland: Jun 6, 2012.  [(accessed on 8 August 2024)]. pp. 261–276. Weekly Epidemiological Record, 87(28–29); Available online:  https://www.who.int/publications/i/item/who-wer8728-29-261-276.</Citation></Reference><Reference><Citation>Gentile C., Alberini I., Manini I., Rossi S., Montomoli E., Pozzi T., Rizzo C., Alfonsi V. Hepatitis A seroprevalence in Tuscany, Italy. Euro Surveill. 2009;14:19146. doi: 10.2807/ese.14.10.19146-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.14.10.19146-en</ArticleId><ArticleId IdType="pubmed">19317984</ArticleId></ArticleIdList></Reference><Reference><Citation>Chironna M., Prato R., Sallustio A., Martinelli D., Tafuri S., Quarto M., Germinario C. Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: Need for strict monitoring and catch-up vaccination. BMC Infect. Dis. 2012;12:271. doi: 10.1186/1471-2334-12-271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-271</ArticleId><ArticleId IdType="pmc">PMC3527327</ArticleId><ArticleId IdType="pubmed">23098290</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdenassi L., Franzini M., Ricevuti G., Rinaldi L., Galoforo A.C., Tirelli U. Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur. Rev. Med. Pharmacol. Sci. 2020;24:4059–4061. doi: 10.26355/eurrev_202004_20976.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202004_20976</ArticleId><ArticleId IdType="pubmed">32374009</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd-Elshafy D.N., Nadeem R., Bahgat M.M. Prevalence of enteric viruses in wastewater in Egypt after the COVID-19 pandemic. J. Water Health. 2022;20:1668–1672. doi: 10.2166/wh.2022.223.</Citation><ArticleIdList><ArticleId IdType="doi">10.2166/wh.2022.223</ArticleId><ArticleId IdType="pubmed">36448616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran S., Xia G.L., Dimitrova Z., Lin Y., Montgomery M., Augustine R., Kamili S., Khudyakov Y. Changing Molecular Epidemiology of Hepatitis A Virus Infection, United States, 1996–2019. Emerg. Infect. Dis. 2021;27:1742–1745. doi: 10.3201/eid2706.203036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2706.203036</ArticleId><ArticleId IdType="pmc">PMC8153864</ArticleId><ArticleId IdType="pubmed">34013865</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>